Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPKAPK5 | Q8IW41 | 11/20 | 0.50 |
| ▸ | BTK | Q06187 | 3/20 | 0.41 |
| ▸ | PTK6 | Q13882 | 1/20 | 0.41 |
| ▸ | JAK2 | O60674 | 1/20 | 0.40 |
| ▸ | JAK1 | P23458 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.38 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.38 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3801487 | 0.91 | MAPKAPK5 (0.61) | MAPKAPK5BTKNPC1RAB9A | |
| SCHEMBL3804104 | 0.89 | MAPKAPK5 (0.41) | MAPKAPK5 | |
| SCHEMBL3803732 | 0.88 | MAPKAPK5 (0.38) | MAPKAPK5BTKJAK2JAK1KCNH2 | |
| SCHEMBL1475246 | 0.88 | MAPKAPK5 (0.62) | MAPKAPK5BTKPTK6JAK2JAK1 | |
| SCHEMBL3796304 | 0.87 | MAPKAPK5 (0.38) | MAPKAPK5BTKJAK2JAK1KCNH2 | |
| SCHEMBL3798987 | 0.86 | MAPKAPK5 (0.51) | MAPKAPK5BTKPTK6JAK2JAK1 | |
| SCHEMBL13918288 | 0.84 | MAPKAPK5 (0.53) | MAPKAPK5BTKPTK6JAK1NPC1 | |
| SCHEMBL3801252 | 0.84 | MAPKAPK5 (0.47) | MAPKAPK5JAK2 | |
| SCHEMBL3798752 | 0.83 | MAPKAPK5 (0.61) | MAPKAPK5MAP4K4 | |
| SCHEMBL3805490 | 0.83 | MAPKAPK5 (0.53) | MAPKAPK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2029602-B1 | TRIAZOLOPYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES | GALAPAGOS NV (BE) | 2010-04-21 | — | — | EP | claimed |